Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last ¥5,990 JPY
Change Today -50.00 / -0.83%
Volume 144.6K
4544 On Other Exchanges
As of 2:00 AM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

miraca holdings inc (4544) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/22/15 - ¥6,160
52 Week Low
10/21/14 - ¥4,125
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MIRACA HOLDINGS INC (4544)

Related News

No related news articles were found.

miraca holdings inc (4544) Related Businessweek News

No Related Businessweek News Found

miraca holdings inc (4544) Details

Miraca Holdings Inc., together with its subsidiaries, provides clinical laboratory testing services in Japan. The company offers its clinical laboratory testing services for collecting and testing biological specimens, such as patient blood or urine. It is also involved in the development, manufacture, and commercialization of in vitro diagnostic reagents and testing devices primarily in the fields of infectious and oncological diseases, medical institutions, and commercial laboratories. In addition, the company offers products for diagnostics of infectious diseases and cancer; clinical trials support services for pharmaceutical research and development operations; and sterilization-outsourcing services, which include retrieving, cleaning, sterilization, and supplying sterilized medical instruments. Further, it offers healthcare-related services, including operational support for medical examination institutions; rents and sells nursing-care equipment and supplies; and sells infection prevention products. Miraca Holdings Inc. was founded in 1950 and is headquartered in Tokyo, Japan.

6,244 Employees
Last Reported Date: 06/24/14
Founded in 1950

miraca holdings inc (4544) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

miraca holdings inc (4544) Key Developments

Miraca Holdings Inc., Nine Months 2015 Earnings Call, Feb 03, 2015

Miraca Holdings Inc., Nine Months 2015 Earnings Call, Feb 03, 2015

Miraca Holdings Inc. Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2014; Provides Earnings Guidance for the Full Year Ending March 31, 2015; Provides Final Dividend Guidance for the Year Ending March 31, 2015

Miraca Holdings Inc. reported consolidated earnings results for the nine months ended December 31, 2014. For the period, net sales were JPY 145,109 million against JPY 152,569 million a year ago. Operating income was JPY 21,402 million against JPY 20,930 million a year ago. Ordinary income was JPY 21,356 million against JPY 21,421 million a year ago. Net income was JPY 13,513 million or JPY 229.93 per diluted share against JPY 12,381 million or JPY 210.81 per diluted share a year ago. Income before income taxes and minority interests was JPY 21,864 million against JPY 20,842 million a year ago. Net cash provided by operating activities was JPY 19,287 million against JPY 20,143 million a year ago. Purchase of property, plant and equipment was JPY 5,358 million against JPY 4,869 million a year ago. Purchase of intangible assets was JPY 5,254 million against JPY 1,958 million a year ago. For the full year ending March 31, 2015, the company expects to report net sales of JPY 212,500 million, operating income of JPY 27,600 million, ordinary income of JPY 27,400 million and net income of JPY 15,900 million or net income per share of JPY 273.10. For the full year ending March 31, 2015, the company expects to declare final dividend of JPY 46.00 per share for a total of JPY 92.00 per share in the year.

Baylor College of Medicine and Miraca Holdings Inc. Finalize Joint Venture on Clinical Genetic Testing

Baylor College of Medicine and Miraca Holdings Inc. finalized a joint venture in which the College will share ownership and governance of its clinical genetics diagnostic laboratories with the Japan-based international healthcare company that has a focus on clinical diagnostics and laboratory tests. The name of the new entity is Baylor Miraca Genetics Laboratories. Baylor Miraca Genetics will be built on Baylor's existing Medical Genetics Laboratories, which engages in clinical laboratory genetic testing. Baylor and Miraca agreed on the terms of the joint venture on Oct. 31, with Dr. Paul Klotman, president, CEO and executive dean of Baylor, and Dr. Hiromasa Suzuki, president and CEO of Miraca, signing the documents in Houston. In the weeks that followed, work was completed on the governmental, business and scientific regulatory approvals needed for closing. The jointly-owned clinical diagnostic venture will be headquartered in Houston, initially in space in the McGovern Building on the McGovern Campus in the Texas Medical Center, the same location as under Baylor.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4544:JP ¥5,990.00 JPY -50.00

4544 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4544.
View Industry Companies

Industry Analysis


Industry Average

Valuation 4544 Industry Range
Price/Earnings 21.5x
Price/Sales 1.7x
Price/Book 2.0x
Price/Cash Flow 14.6x
TEV/Sales 1.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MIRACA HOLDINGS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at